Enapotamab Vedotin
Enapotamab Vedotin Uses, Dosage, Side Effects, Food Interaction and all others data.
Enapotamab Vedotin is under investigation in clinical trial NCT02988817 (Enapotamab Vedotin (Humax-axl-adc) Safety Study in Patients With Solid Tumors).
| Trade Name | Enapotamab Vedotin |
| Generic | Enapotamab vedotin |
| Enapotamab vedotin Other Names | Enapotamab vedotin, Humax axl adc, HuMax-AXL-ADC, Immunoglobulin g1, anti-(human growth factor receptor axl)(human humax-axl .gamma.1-chain), disulfide with human humax-axl .kappa.-chain, dimer tetrakis(thioether) with vedotin |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Enapotamab Vedotin
